The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
<h4>Background</h4>Yes-associated protein 1 (YAP1) is a key effector molecule regulated by the Hippo pathway and described as a poor prognostic factor in breast cancer. Tumor protein 53 (TP53) mutation is well known as a biomarker related to poor survival outcomes. So far clinical charac...
Guardado en:
Autores principales: | Yoon Jin Cha, Dooreh Kim, Soong June Bae, Sung Gwe Ahn, Joon Jeong, Min Kyung Cho, Pill Sun Paik, Tae-Kyung Yoo, Woo-Chan Park, Chang Ik Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17de6630c8b04eb7ad5fe3cea0909380 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
por: Yoon Jin Cha, et al.
Publicado: (2021) -
Relationship of the standard uptake value of 18F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Soeun Park, et al.
Publicado: (2021) -
New Insights into the Roles of Yes-Associated Protein (YAP1) in Colorectal Cancer Development and Progression
por: Fariba Dehghanian, et al.
Publicado: (2019) -
Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy
por: Guimei M, et al.
Publicado: (2020) -
Dynamic patterns of YAP1 expression and cellular localization in the developing and injured utricle
por: Vikrant Borse, et al.
Publicado: (2021)